한글목차

의료기기 엔지니어링 시장 규모는 예측 기간 동안 10.8%의 연평균 복합 성장률(CAGR)로 확대되고 2024년 120억 달러에서 2029년에는 201억 달러에 이를 것으로 예측됩니다.

의료기기 제조업체 중 일부는 엔지니어링 서비스 제공업체와 제휴하여 시장에 새로운 혁신을 가져오고 능력을 높이는 기업이 늘고 있습니다. 이러한 제휴를 통해 기업은 엔지니어링 서비스 제공업체가 보유한 특정 전문 기술, 최첨단 기술 및 완전한 R&D 시설을 자유롭게 이용할 수 있습니다. 이러한 제휴는 혁신적인 의료기기 개발을 가속화하고 규제 준수를 간소화하며 시장 출시 시간을 단축합니다. 또한 모범 사례와 지식을 공유함으로써 공동 개발의 개발 환경을 향상시킬 수 있습니다. 이러한 시너지 효과는 자원 활용을 최적화할 뿐만 아니라 새로운 의료기기가 안전하고 효과적이며 시장 요구를 갖게 합니다.

소프트웨어 개발 및 테스트 서비스 분야는 예측 기간 동안 최고의 CAGR을 경험할 것으로 예상됩니다. 의료 서비스 제공업체와 환자는 각 환자의 필요와 선호도에 대응할 수 있도록 보다 개별화된 의료 솔루션을 찾고 있습니다. 장비 개발 및 테스트 서비스를 제공함으로써 적응 제어 알고리즘, 사용자 인터페이스 개인화, 심지어 다른 헬스케어 시스템과의 상호 운용성 등을 이용하여 소정의 요건에 맞게 장비를 커스터마이징할 여지가 태어납니다.

신흥경제국가를 중심으로 헬스케어 인프라의 급속한 개척이 진행되고 있기 때문에 예측기간 중 세계 의료기기 엔지니어링 시장에서 영상 진단기기 분야가 가장 높은 CAGR로 성장할 것으로 예측됩니다. 이 지역에서는 많은 새로운 병원과 진단센터가 건설되고 있으며, 이러한 병원과 진단센터는 모두 고급 이미지 처리 기술을 갖추고 있습니다. 첨단 진단 도구의 고해상도와 3D 이미지는 진단의 정확성과 속도를 향상시킵니다. 이미지 분석 절차에 AI와 ML의 통합이 진행되면 이미지 분석과 해석이 향상됩니다. 이러한 첨단 의료 시설과 첨단 기술의 성장은 이미징 장비의 부문을 빠르게 밀어 올리고 있습니다.

본 보고서에서는 세계의 의료기기 엔지니어링 시장에 대해 조사했으며,, 서비스 유형별, 서비스 시설 유형별, 디바이스 유형별, 지역별 동향 및 시장 진출기업 프로파일 등을 정리했습니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 중요 인사이트

제5장 시장 개요

• 소개
• 시장 역학
• 업계 동향
• 기술 분석
• 밸류체인 분석
• 공급망 분석
• Porter's Five Forces 분석
• 규제 상황
• 특허 분석
• 가격 분석
• 무역 분석
• 2024-2025년의 주된 회의와 이벤트
• 주요 이해관계자와 구매 기준
• 의료기기 엔지니어링 시장에서 생성형 AI의 영향
• 생태계 분석
• 사례 연구 분석
• 고객의 비즈니스에 영향을 미치는 동향/혼란
• 의료기기 엔지니어링 시장 : 투자 및 자금 조달 시나리오

제6장 의료기기 엔지니어링 시장(서비스 유형별)

• 소개
• 제품이노베이션 및 디자인/공업디자인서비스
• 프로토타이핑 서비스
• 전자공학 서비스
• 소프트웨어 개발 및 테스트 서비스
• 커넥티비티 및 모빌리티 서비스
• 사이버 보안 서비스
• 제품 테스트 서비스
• 규제 컨설팅 서비스
• 제품 지원 및 유지 보수 서비스

제7장 의료기기 엔지니어링 시장(서비스 시설 유형별)

• 소개
• 엔지니어링 서비스 제공업체(ESPS)
• 세계 역량 센터(GCCS)
• 사내 서비스

제8장 의료기기 엔지니어링 시장(디바이스 유형별)

• 소개
• 진단용 화상 기기
• 환자 모니터링 및 생명 유지 장치
• 외과용 기기
• 의료용 레이저
• IVD 디바이스
• 기타

제9장 의료기기 엔지니어링 시장(지역별)

• 소개
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제10장 경쟁 구도

• 개요
• 주요 진입기업의 전략/비책
• 수익분배분석
• 시장 점유율 분석
• 의료기기 엔지니어링 서비스 벤더의 기업 평가 및 재무 지표
• 기업평가 매트릭스: 주요 진입기업, 2023년
• 기업평가 매트릭스: 스타트업/중소기업, 2023년
• 경쟁 구도와 동향
• 브랜드/제품 비교 분석
• 의료기기 엔지니어링 시장 : 연구 개발비

제11장 기업 프로파일

• 주요 진출기업
  • L&T TECHNOLOGY SERVICES LIMITED(LTTS)
  • INFOSYS LIMITED
  • HCL TECHNOLOGIES LIMITED
  • TATA CONSULTANCY SERVICES LIMITED
  • CYIENT
  • WIPRO LIMITED
  • TECH MAHINDRA LIMITED
  • CAPGEMINI
  • ACCENTURE PLC
  • ALTEN GROUP
  • FLEX LTD
  • ALTHEA GROUP
  • EMBIEN TECHNOLOGIES INDIA PVT LTD.
  • SARACA SOLUTIONS PRIVATE LIMITED
  • CONSONANCE
  • MED INSTITUTE
• 기타 기업
  • NEMEDIO INC.
  • STERNUM
  • MEDCRYPT
  • MCRA, LLC
  • NORTH AMERICAN SCIENCE ASSOCIATES, LLC
  • MEDQTECH AB
  • ONTOGEN MEDTECH LLC
  • SEISA MEDICAL
  • SIMPLEXITY PRODUCT DEVELOPMENT
  • VERANEX

제12장 부록

영문목차

The medical device engineering market is projected to reach USD 20.1 Billion by 2029 from USD 12.0 Billion in 2024 at a CAGR of 10.8% during the forecast period. An increasing number of medical device companies are collaborating with engineering service providers to bring new innovations and enhance capabilities in the market. These partnerships help a company avail specific professional skills, state-of-the-art technologies, and full R&D facilities that an engineering service provider has at its disposal. Such collaborations will fast-track the development of innovative medical devices and simplify regulatory compliance, reducing time-to-market. This enables sharing of best practices and knowledge to advance the development environment in the collaborative effort. This synergy not only optimizes resource utilization but also allows for a new medical device to be safe, effective, and have a market need.

"The software development & testing services segment is projected to experience the highest CAGR during the forecast period."

The software development & testing services segment is projected to experience the highest CAGR during the forecast period. Healthcare providers and patients seek out more individualized medical solutions to be able to meet each patient's needs and preferences. With the offering of development and testing services on devices, comes the scope for customization of a device to suit the given requirements using adaptive control algorithms, user interface personalization, or even interoperability with other healthcare systems.

"Diagnostic imaging equipment segment projected the rapid growth during the forecast period."

The diagnostic imaging equipment segment will grow at the highest CAGR in the global medical device engineering market during the forecast period, as there has been rapid development in healthcare infrastructure, especially in emerging economies. Most of these regions are having many new hospitals and diagnostic centers; all these hospitals and diagnostic centers are well-equipped with advanced imaging technologies. High-resolution and 3D imaging in advanced diagnostic tools raise the accuracy and speed of diagnosis; greater integration of AI and ML into the image analysis procedure enhances image analysis and interpretation. This growth in advanced healthcare facilities and state-of-the-art technologies is boosting the segment for diagnostic imaging equipment quite rapidly.

"North America to witness the substantial growth rate during the forecast period."

The medical device engineering market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa based on the region type. In 2023, the Asia Pacific region is anticipated to exhibit the highest compound annual growth rate (CAGR) during the forecast period. However, North America holds the largest share of the medical device engineering market in 2023. One of the major factors behind North America's leading position in the medical device engineering market is its robust economic strength. This region's high spending toward healthcare ensures that funding for medical equipment innovations and enhancements never comes to a halt. Proper medical care also ensures that the patients recover better, hence demanding more developed medical devices. This optimistic economic outlook attracts hefty investments in R&D, thus providing for the development and deployment of new and innovative technologies for medical applications. This is a region that offers access to the best engineering talent, as well as enables close collaboration among the industry leaders, leading-edge research institutions, and innovative healthcare providers in further building and fine-tuning medical device engineering.

A breakdown of the primary participants (supply-side) for the medical device engineering market referred to for this report is provided below:

• By Company Type: Tier 1-45%, Tier 2-34%, and Tier 3-21%
• By Designation: C-level-26%, Director Level-30%, and Others-44%
• By Region: North America-35%, Europe-32%, Asia Pacific-25%, Latin America- 6%, and Middle East and Africa- 2%

Prominent players in this market include L&T Technology Services Limited (India), Infosys Limited (India), HCL Technologies Limited (India), Cyient (India), Wipro (India), Tech Mahindra Limited (India), TATA Consultancy Services Limited (India), FLEX LTD (US), Capgemini (France), Embien Technologies India Pvt Ltd. (India), Alten Group (France), Accenture (Ireland), Consonance (Poland), Althea Group (US), MED INSTITUTE (US), Saraca Solutions Private Limited (India), Nemedio Inc. (US), Sternum (Israel), Medcrypt (US), MCRA, LLC (US), North American Science Associates, LLC (US), MedQtech (Sweden), Veranex (US), Ontogen Medtech LLC (US), Seisa Media (US), and Simplexity Product Development (US).

Research Coverage:

The market study covers the medical device engineering market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by service type, device type, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

• Analysis of Market Dynamics: Drivers (growing demand for medical devices driven by aging population and chronic disease incidence boosts need for advanced engineering services, industry 4.0 significantly impacting the medical device engineering market, and ensuring regulatory compliance and stringent quality controls drives expansion of medical device engineering market) restraints (high costs and investment demands will constrain growth) opportunities (growing complexities of medical devices, and strategic collaborations and acquisitions between market players to boost the innovation in medical device engineering), and challenges (survival of small players in highly fragmented and competitive market, and concerns about cybersecurity)
• Services/Innovations: Detailed insights on upcoming technologies, research & development activities, and new service launches in the medical device engineering market.
• Market Development: Comprehensive information on the lucrative emerging markets, components, demographics, end-user, and region.
• Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the medical device engineering market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the medical device engineering market like L&T Technology Services Limited (India), Infosys Limited (India), HCL Technologies Limited (India), Cyient (India), TATA Consultancy Services Limited (India) among others.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION
  • 1.3.2 INCLUSIONS & EXCLUSIONS
• 1.4 YEARS CONSIDERED
• 1.5 CURRENCY CONSIDERED
• 1.6 LIMITATIONS
• 1.7 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
• 2.2 MARKET SIZE ESTIMATION AND FORECAST
  • 2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
  • 2.2.2 GROWTH FORECAST
  • 2.2.3 PRIMARY RESEARCH VALIDATION
• 2.3 DATA TRIANGULATION
• 2.4 STUDY ASSUMPTIONS
• 2.5 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 MEDICAL DEVICE ENGINEERING MARKET OVERVIEW
• 4.2 ASIA PACIFIC: MEDICAL DEVICE ENGINEERING MARKET, BY DEVICE TYPE AND COUNTRY
• 4.3 MEDICAL DEVICE ENGINEERING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
• 4.4 REGIONAL MIX: MEDICAL DEVICE ENGINEERING MARKET
• 4.5 MEDICAL DEVICE ENGINEERING MARKET: DEVELOPED VS. DEVELOPING MARKETS

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Aging population coupled with rise in chronic disease incidence
    • 5.2.1.2 Advances introduced by Industry 4.0
    • 5.2.1.3 Need to ensure regulatory compliance and stringent quality controls
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High costs and investment demands
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Growing complexities of technology surrounding medical devices
    • 5.2.3.2 Strategic collaborations and acquisitions between market players
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Survival of small players in highly fragmented and competitive market
• 5.3 INDUSTRY TRENDS
  • 5.3.1 HUMAN FACTORS ENGINEERING
  • 5.3.2 INCREASED OUTSOURCING
  • 5.3.3 TELEMEDICINE INTEGRATION
• 5.4 TECHNOLOGY ANALYSIS
  • 5.4.1 KEY TECHNOLOGIES
    • 5.4.1.1 Artificial Intelligence (AI) and Machine Learning (ML)
    • 5.4.1.2 Internet of Medical Things (IoMT)
  • 5.4.2 COMPLEMENTARY TECHNOLOGIES
    • 5.4.2.1 3D Printing and additive manufacturing
    • 5.4.2.2 Cybersecurity technologies
  • 5.4.3 ADJACENT TECHNOLOGIES
    • 5.4.3.1 Wearable technology
    • 5.4.3.2 Cloud computing
• 5.5 VALUE CHAIN ANALYSIS
• 5.6 SUPPLY CHAIN ANALYSIS
• 5.7 PORTER'S FIVE FORCES ANALYSIS
  • 5.7.1 THREAT OF NEW ENTRANTS
    • 5.7.1.1 High capital investment
    • 5.7.1.2 Regulatory hurdles
    • 5.7.1.3 Established client relationships
  • 5.7.2 THREAT OF SUBSTITUTES
    • 5.7.2.1 Alternative solutions
    • 5.7.2.2 Technological advances
    • 5.7.2.3 Customer loyalty
  • 5.7.3 BARGAINING POWER OF SUPPLIERS
    • 5.7.3.1 Supplier concentration
    • 5.7.3.2 Switching costs
    • 5.7.3.3 Supplier integration
  • 5.7.4 BARGAINING POWER OF BUYERS
    • 5.7.4.1 Buyer concentration
    • 5.7.4.2 Product differentiation
    • 5.7.4.3 Availability of alternative service providers
  • 5.7.5 INTENSITY OF COMPETITIVE RIVALRY
    • 5.7.5.1 Fragmented market
    • 5.7.5.2 Standardization of services
    • 5.7.5.3 Innovation
• 5.8 REGULATORY LANDSCAPE
  • 5.8.1 NORTH AMERICA
    • 5.8.1.1 US
  • 5.8.2 EUROPE
  • 5.8.3 ASIA PACIFIC
    • 5.8.3.1 Japan
    • 5.8.3.2 China
    • 5.8.3.3 India
  • 5.8.4 REST OF THE WORLD
  • 5.8.5 REGULATORY STANDARDS
    • 5.8.5.1 ISO standards
    • 5.8.5.2 ISO 9001:2015
    • 5.8.5.3 ISO 13485:2016
  • 5.8.6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.9 PATENT ANALYSIS
  • 5.9.1 PATENT PUBLICATION TRENDS FOR MEDICAL DEVICE ENGINEERING
  • 5.9.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
• 5.10 PRICING ANALYSIS
  • 5.10.1 AVERAGE SELLING PRICE MEDICAL DEVICE REGULATORY CONSULTING SERVICES FOR KEY VENDOR, BY REGION
  • 5.10.2 INDICATIVE PRICING, BY SERVICE TYPE
• 5.11 TRADE ANALYSIS
  • 5.11.1 INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, DENTAL OR VETERINARY SCIENCES (HS CODE 9018)
  • 5.11.2 IMPORT SCENARIO
  • 5.11.3 EXPORT SCENARIO
• 5.12 KEY CONFERENCES AND EVENTS, 2024-2025
• 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.13.2 BUYING CRITERIA
• 5.14 IMPACT OF GENERATIVE AI ON MEDICAL DEVICE ENGINEERING MARKET
• 5.15 ECOSYSTEM ANALYSIS
• 5.16 CASE STUDY ANALYSIS
• 5.17 TRENDS/DISRUPTIONS AFFECTING CUSTOMERS' BUSINESSES
• 5.18 MEDICAL DEVICE ENGINEERING MARKET: INVESTMENT AND FUNDING SCENARIO

6 MEDICAL DEVICE ENGINEERING MARKET, BY SERVICE TYPE

• 6.1 INTRODUCTION
• 6.2 PRODUCT INNOVATION & DESIGN/INDUSTRIAL DESIGN SERVICES
• 6.3 PROTOTYPING SERVICES
• 6.4 ELECTRONIC ENGINEERING SERVICES
• 6.5 SOFTWARE DEVELOPMENT & TESTING SERVICES
• 6.6 CONNECTIVITY & MOBILITY SERVICES
• 6.7 CYBERSECURITY SERVICES
• 6.8 PRODUCT TESTING SERVICES
• 6.9 REGULATORY CONSULTING SERVICES
• 6.10 PRODUCT SUPPORT & MAINTENANCE SERVICES

7 MEDICAL DEVICE ENGINEERING MARKET, BY SERVICE FACILITY TYPE

• 7.1 INTRODUCTION
• 7.2 ENGINEERING SERVICE PROVIDERS (ESPS)
• 7.3 GLOBAL CAPABILITY CENTERS (GCCS)
• 7.4 IN-HOUSE SERVICES

8 MEDICAL DEVICE ENGINEERING MARKET, BY DEVICE TYPE

• 8.1 INTRODUCTION
• 8.2 DIAGNOSTIC IMAGING EQUIPMENT
• 8.3 PATIENT MONITORING & LIFE SUPPORT DEVICES
• 8.4 SURGICAL EQUIPMENT
• 8.5 MEDICAL LASERS
• 8.6 IVD DEVICES
• 8.7 OTHER MEDICAL DEVICES

9 MEDICAL DEVICE ENGINEERING MARKET, BY REGION

• 9.1 INTRODUCTION
• 9.2 NORTH AMERICA
  • 9.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK
  • 9.2.2 US
    • 9.2.2.1 Financial backing for better and accessible technology, along with rise in incidence of lifestyle diseases
  • 9.2.3 CANADA
    • 9.2.3.1 Robust regulatory environment in Canada
• 9.3 EUROPE
  • 9.3.1 EUROPE: MACROECONOMIC OUTLOOK
  • 9.3.2 GERMANY
    • 9.3.2.1 Largest market share in Europe supported by high utilization of diagnostic imaging systems
  • 9.3.3 UK
    • 9.3.3.1 Government Initiatives, funding, and regulatory reforms to drive innovation
  • 9.3.4 FRANCE
    • 9.3.4.1 Combination of demographic trends, increase in disease prevalence, and significant government funding
  • 9.3.5 ITALY
    • 9.3.5.1 High focus on value-based healthcare systems
  • 9.3.6 SPAIN
    • 9.3.6.1 Growth in investments in advanced technologies and budget constraints for new equipment
  • 9.3.7 REST OF EUROPE
• 9.4 ASIA PACIFIC
  • 9.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK
  • 9.4.2 JAPAN
    • 9.4.2.1 High adoption rate of premium medical technologies and increase in geriatric population
  • 9.4.3 CHINA
    • 9.4.3.1 Push toward technological self-reliance and growth in demand for premium-priced medical devices
  • 9.4.4 INDIA
    • 9.4.4.1 Growth in FDI influx in healthcare and increase in medical tourism
  • 9.4.5 AUSTRALIA
    • 9.4.5.1 Substantial government funding and favorable regulatory environment
  • 9.4.6 SOUTH KOREA
    • 9.4.6.1 Rapid technological advancement with presence of prominent digital equipment manufacturers and robust government support
  • 9.4.7 REST OF ASIA PACIFIC
• 9.5 LATIN AMERICA
  • 9.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK
  • 9.5.2 BRAZIL
    • 9.5.2.1 Rising awareness about advanced diagnostic and treatment procedures
  • 9.5.3 MEXICO
    • 9.5.3.1 Favorable investment scenario for medical device manufacturers
  • 9.5.4 REST OF LATIN AMERICA
• 9.6 MIDDLE EAST & AFRICA
  • 9.6.1 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
  • 9.6.2 GCC COUNTRIES
    • 9.6.2.1 Higher disposable incomes to offset lower healthcare spending due to effects of economic downturn
  • 9.6.3 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

• 10.1 OVERVIEW
• 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
• 10.3 REVENUE SHARE ANALYSIS
• 10.4 MARKET SHARE ANALYSIS
• 10.5 COMPANY VALUATION AND FINANCIAL METRICS OF MEDICAL DEVICE ENGINEERING SERVICE VENDORS
• 10.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 10.6.1 STARS
  • 10.6.2 EMERGING LEADERS
  • 10.6.3 PERVASIVE PLAYERS
  • 10.6.4 PARTICIPANTS
  • 10.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 10.6.5.1 Company footprint
    • 10.6.5.2 Service type footprint
    • 10.6.5.3 Device type footprint
    • 10.6.5.4 Regional footprint
• 10.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 10.7.1 PROGRESSIVE COMPANIES
  • 10.7.2 RESPONSIVE COMPANIES
  • 10.7.3 DYNAMIC COMPANIES
  • 10.7.4 STARTING BLOCKS
  • 10.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    • 10.7.5.1 Detailed list of key startup/SME players
    • 10.7.5.2 Competitive benchmarking of key startup/SME players
• 10.8 COMPETITIVE SITUATION AND TRENDS
  • 10.8.1 DEALS
  • 10.8.2 EXPANSIONS
  • 10.8.3 DEVELOPMENTS
• 10.9 BRAND/PRODUCT COMPARATIVE ANALYSIS
• 10.10 MEDICAL DEVICE ENGINEERING MARKET: R&D EXPENDITURE

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
  • 11.1.1 L&T TECHNOLOGY SERVICES LIMITED (LTTS)
    • 11.1.1.1 Business overview
    • 11.1.1.2 Services offered
    • 11.1.1.3 Recent developments
      • 11.1.1.3.1 Deals
      • 11.1.1.3.2 Expansions
    • 11.1.1.4 MnM view
      • 11.1.1.4.1 Right to win
      • 11.1.1.4.2 Strategic choices
      • 11.1.1.4.3 Weaknesses & competitive threats
  • 11.1.2 INFOSYS LIMITED
    • 11.1.2.1 Business overview
    • 11.1.2.2 Services offered
    • 11.1.2.3 Recent developments
      • 11.1.2.3.1 Deals
    • 11.1.2.4 MnM view
      • 11.1.2.4.1 Right to win
      • 11.1.2.4.2 Strategic choices
      • 11.1.2.4.3 Weaknesses & competitive threats
  • 11.1.3 HCL TECHNOLOGIES LIMITED
    • 11.1.3.1 Business overview
    • 11.1.3.2 Services offered
    • 11.1.3.3 Recent developments
      • 11.1.3.3.1 Deals
      • 11.1.3.3.2 Expansions
    • 11.1.3.4 MnM view
      • 11.1.3.4.1 Right to win
      • 11.1.3.4.2 Strategic choices
      • 11.1.3.4.3 Weaknesses & competitive threats
  • 11.1.4 TATA CONSULTANCY SERVICES LIMITED
    • 11.1.4.1 Business overview
    • 11.1.4.2 Services offered
    • 11.1.4.3 Recent developments
      • 11.1.4.3.1 Developments
    • 11.1.4.4 MnM view
      • 11.1.4.4.1 Right to win
      • 11.1.4.4.2 Strategic choices
      • 11.1.4.4.3 Weaknesses & competitive threats
  • 11.1.5 CYIENT
    • 11.1.5.1 Business overview
    • 11.1.5.2 Services offered
    • 11.1.5.3 Recent developments
    • 11.1.5.4 MnM view
      • 11.1.5.4.1 Right to win
      • 11.1.5.4.2 Strategic choices
      • 11.1.5.4.3 Weaknesses & competitive threats
  • 11.1.6 WIPRO LIMITED
    • 11.1.6.1 Business overview
    • 11.1.6.2 Services offered
    • 11.1.6.3 Recent developments
  • 11.1.7 TECH MAHINDRA LIMITED
    • 11.1.7.1 Business overview
    • 11.1.7.2 Services offered
    • 11.1.7.3 Recent developments
      • 11.1.7.3.1 Developments
  • 11.1.8 CAPGEMINI
    • 11.1.8.1 Business overview
    • 11.1.8.2 Services offered
    • 11.1.8.3 Recent developments
      • 11.1.8.3.1 Developments
  • 11.1.9 ACCENTURE PLC
    • 11.1.9.1 Business overview
    • 11.1.9.2 Services offered
    • 11.1.9.3 Recent developments
  • 11.1.10 ALTEN GROUP
    • 11.1.10.1 Business overview
    • 11.1.10.2 Services offered
    • 11.1.10.3 Recent developments
      • 11.1.10.3.1 Deals
  • 11.1.11 FLEX LTD
    • 11.1.11.1 Business overview
    • 11.1.11.2 Services offered
    • 11.1.11.3 Recent developments
  • 11.1.12 ALTHEA GROUP
    • 11.1.12.1 Business overview
    • 11.1.12.2 Services offered
    • 11.1.12.3 Recent developments
  • 11.1.13 EMBIEN TECHNOLOGIES INDIA PVT LTD.
    • 11.1.13.1 Business overview
    • 11.1.13.2 Services offered
    • 11.1.13.3 Recent developments
      • 11.1.13.3.1 Deals
  • 11.1.14 SARACA SOLUTIONS PRIVATE LIMITED
    • 11.1.14.1 Business overview
    • 11.1.14.2 Services offered
    • 11.1.14.3 Recent developments
  • 11.1.15 CONSONANCE
    • 11.1.15.1 Business overview
    • 11.1.15.2 Services offered
    • 11.1.15.3 Recent developments
  • 11.1.16 MED INSTITUTE
    • 11.1.16.1 Business overview
    • 11.1.16.2 Services offered
    • 11.1.16.3 Recent developments
• 11.2 OTHER PLAYERS
  • 11.2.1 NEMEDIO INC.
  • 11.2.2 STERNUM
  • 11.2.3 MEDCRYPT
  • 11.2.4 MCRA, LLC
  • 11.2.5 NORTH AMERICAN SCIENCE ASSOCIATES, LLC
  • 11.2.6 MEDQTECH AB
  • 11.2.7 ONTOGEN MEDTECH LLC
  • 11.2.8 SEISA MEDICAL
  • 11.2.9 SIMPLEXITY PRODUCT DEVELOPMENT
  • 11.2.10 VERANEX

12 APPENDIX

• 12.1 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.2 CUSTOMIZATION OPTIONS
• 12.3 AUTHOR DETAILS